AHSCX
Price
$11.42
Change
-$0.10 (-0.87%)
Updated
Apr 3 closing price
Net Assets
71.21M
JFNIX
Price
$67.12
Change
-$0.85 (-1.25%)
Updated
Apr 3 closing price
Net Assets
4.95B
Ad is loading...

AHSCX vs JFNIX

Header iconAHSCX vs JFNIX Comparison
Open Charts AHSCX vs JFNIXBanner chart's image
Alger Health Sciences C
Price$11.42
Change-$0.10 (-0.87%)
VolumeN/A
Net Assets71.21M
Janus Henderson Global Life Sciences I
Price$67.12
Change-$0.85 (-1.25%)
VolumeN/A
Net Assets4.95B
AHSCX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AHSCX vs. JFNIX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AHSCX is a Buy and JFNIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.95B vs. AHSCX (71.2M). JFNIX pays higher dividends than AHSCX: JFNIX (0.39) vs AHSCX (0.00). AHSCX was incepted earlier than JFNIX: AHSCX (23 years) vs JFNIX (16 years). AHSCX (1.90) is less costly to investors than JFNIX (0.77). AHSCX is a more actively managed with annual turnover of: 233.38 vs. JFNIX (35.00). AHSCX has a lower initial minimum investment than JFNIX: AHSCX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -6.45 vs. AHSCX (-15.17). JFNIX return over 5 years is better than : 35.56 vs. AHSCX (-35.87).
AHSCXJFNIXAHSCX / JFNIX
Total Expense Ratio1.900.77247%
Annual Report Gross Expense Ratio1.900.77247%
Fund Existence23 years16 years-
Gain YTD-10.329-0.07414,052%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets71.2M4.95B1%
Annual Yield % from dividends0.000.39-
Returns for 1 year-15.17-6.45235%
Returns for 3 years-23.092.72-847%
Returns for 5 years-35.8735.56-101%
Returns for 10 years-44.0419.64-224%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYMCX6.950.10
+1.46%
Royce Micro-Cap Consult
APDRX31.200.24
+0.78%
Artisan Global Opportunities Advisor
OTCHX26.72N/A
N/A
MFS Mid Cap Growth R3
BINCX19.56N/A
N/A
Brandes International Small Cap Equity C
BGEAX30.91N/A
N/A
Brandes Global Equity A